… HPV vaccination in women aged over 25 years, ie, beyond the maximum age range for
current mass vaccination … beyond the age of 18 worldwide despite the fact that vaccine efficacy …

… % efficacy and coverage of an HPV 16/18 vaccine, our results suggest that the vaccine could
prevent at least 23% of all CIN 3 lesions. If it is also anticipated that HPV 16/18 is the causal …

… affirm that prophylactic HPV vaccination is safe and prevents the acquisition of target HPV
genotypes at any age, and that any woman could benefit from HPV vaccination. However, cost-…

… about HPV and HPV vaccination in a population of women ages 19 to 26 seeking services
at reproductive health centers. A secondary aim was to identify common sources of HPV …

… This study extends previous observations of quadrivalent HPV vaccine impact and … HPV
vaccination in the United States among females aged 14 to 19 years and extend the findings to …

… and quadrivalent HPV vaccines prevent essentially all new … associated with vaccine-targeted
HPV types in females aged 15 … focused on age considerations regarding HPV vaccination. …

… HPV vaccination initiation and completion by selected demographic characteristics among
adults aged … received one or more doses of HPV vaccine, women were more likely than men …

… Respondents were more likely to be aware of HPV and HPV vaccination if they were female,
had a higher level of education, and had previous cancer information seeking behaviors. …

… was subsidized for girls in Sweden who were 13 to 17 years of age. In 2012, … HPV vaccination
program for girls and women 13 to 18 years of age and a school-based HPV vaccination …

… The cost-effectiveness of HPV vaccination will depend on the duration of vaccine immunity
… initial catch-up efforts to women up to 18 or 21 years of age, and revising screening policies. …